Alpine Immune Sciences Stock Market Capitalization
Alpine Immune Sciences fundamentals help investors to digest information that contributes to Alpine Immune's financial success or failures. It also enables traders to predict the movement of Alpine Stock. The fundamental analysis module provides a way to measure Alpine Immune's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alpine Immune stock.
Alpine |
Alpine Immune Sciences Company Market Capitalization Analysis
Alpine Immune's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Alpine Immune Market Capitalization | 4.46 B |
Most of Alpine Immune's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alpine Immune Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Alpine Immune Sciences is about 4.46 B. This is 65.56% lower than that of the Biotechnology sector and 5.99% lower than that of the Health Care industry. The market capitalization for all United States stocks is 76.58% higher than that of the company.
Alpine Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alpine Immune's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alpine Immune could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics of similar companies.Alpine Immune is currently under evaluation in market capitalization category among its peers.
Alpine Fundamentals
Return On Equity | -0.15 | |||
Return On Asset | -0.1 | |||
Profit Margin | (0.65) % | |||
Operating Margin | (3.23) % | |||
Current Valuation | 4.16 B | |||
Shares Outstanding | 68.6 M | |||
Shares Owned By Insiders | 4.60 % | |||
Shares Owned By Institutions | 99.46 % | |||
Number Of Shares Shorted | 3.89 M | |||
Price To Earning | (32.69) X | |||
Price To Book | 12.87 X | |||
Price To Sales | 71.68 X | |||
Revenue | 58.88 M | |||
Gross Profit | (40.18 M) | |||
EBITDA | (43.67 M) | |||
Net Income | (32.18 M) | |||
Cash And Equivalents | 167.86 M | |||
Cash Per Share | 5.52 X | |||
Total Debt | 9.91 M | |||
Debt To Equity | 0.17 % | |||
Current Ratio | 2.75 X | |||
Book Value Per Share | 5.08 X | |||
Cash Flow From Operations | (79.01 M) | |||
Short Ratio | 0.96 X | |||
Earnings Per Share | (0.64) X | |||
Target Price | 62.0 | |||
Number Of Employees | 142 | |||
Beta | 0.97 | |||
Market Capitalization | 4.46 B | |||
Total Asset | 381.81 M | |||
Retained Earnings | (256.14 M) | |||
Working Capital | 288.05 M | |||
Current Asset | 25.53 M | |||
Current Liabilities | 3.39 M | |||
Net Asset | 381.81 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Alpine Stock
If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |